With respect to possible enforcement of this policy, in FDAs press release FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize issued on October 2, FDA stated: FDA reminds compounders of the legal restrictions on making copies of FDA-approved drugs. This language suggests that FDA, in conjunction of with state Boards of Pharmacy may pursue enforcement action against compounders that continue to compound with this ingredient and possibly related combinations outside of the guidance and exemptions noted above
Perifusion measurements to determine rates of insulin secretion Insulin production was evaluated using a commercially available perifusion system (BaroFuse
Ingredients: 1 large head of cauliflower, cut into florets 1/4 cup unsweetened almond milk 2 tbsp butter (or olive oil) 2 cloves garlic, minced Salt and pepper to taste Fresh chives, chopped (for garnish) Instructions: Steam or boil the cauliflower florets until tender, about 10 minutes
UPDATE: Not surprisingly, on June 20, 2023, Novo Nordisk announced that it had filed lawsuits for trademark infringement and other claims relating to false advertising by the defendants in those cases
Phase 2 Trial Adverse Event Data (NEJM, 2023) The pivotal Phase 2 trial (n=338) randomized participants across multiple dose levels over 48 weeks
The effects most users encounter are gastrointestinal and tied to oral dosing